Hemolysis induced cross-matching difficulty with intravenous immunoglobulin: a case report
Abstract Background Intravenous immunoglobulin is one of the most common modalities of treatment for Guillain–Barré syndrome. Although minor complications are easily preventable with pre-medications, rare complications like hemolysis occur at unexpected times and carry risks of repeated transfusions...
Main Authors: | Achyut Sharma, Diptesh Aryal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-018-1774-0 |
Similar Items
-
Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome
by: J Gordon Millichap
Published: (2010-01-01) -
Intravenous immunoglobulin-associated hemolysis: risk factors, challenges, and solutions
by: Mohamed M
Published: (2016-10-01) -
Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome
by: Nandagopal Nithyashree, et al.
Published: (2014-01-01) -
Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study
by: Md. Badrul Islam, et al.
Published: (2017-09-01) -
The Production Processes and Biological Effects of Intravenous Immunoglobulin
by: Ana Filipa Barahona Afonso, et al.
Published: (2016-03-01)